Healthcare DIVE May 8, 2024
Rebecca Pifer

Heightened antitrust scrutiny from state governments and regulators in Washington is depressing deals, according to Pitchbook analysts.

Dive Brief:

  • Private equity investing in healthcare services is continuing to fall, highlighting the chilling effect of heightened antitrust scrutiny in the space, according to a new report.
  • PE firms announced or closed just below 160 deals in the first quarter, a downward trend “even from 2023’s sluggish pace,” according to the analysis by market data research firm PitchBook. The total is down almost a third from the fourth quarter last year.
  • Despite the depression, firms have deals in the pipeline that should progress, albeit slowly, the report says. Announcements are expected to trickle in toward the end of this year, with...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Investments, Mergers & Acquisitions / JV, Survey / Study, Trends
CNS-Focused Rapport Therapeutics Preps IPO to Back Phase 2-Ready Epilepsy Drug
How the wealth of 10 physician billionaires has evolved
Fierce Fundraising Tracker—SmarterDx nabs $50M for clinical AI
R3 Vascular raises $87M to test its bioresorbable scaffold for blocked arteries below the knee
CoreWeave Secures $7.5 Billion to Expand AI Infrastructure

Share This Article